Review
Open access
Efficacy and Safety of Dual GLP‐1/Glucagon Receptor Agonism in Overweight and Obesity: A Class‐Specific Systematic Review and Meta‐Analysis
M. Amjad
Muhammad Mustafa Khan
Fatima Sarwar
Aqsa Ali
Maham Ali
Faiza Bakhash
Humna Abid
F. Ibrahim
Kashaf Mustafa
Dur-E-Najaf Ali
M. Fayyaz
Huma Hassan
Safwan Masaud Mian
Muhammad Yaseen
Ihsan Qamar
A. H. Khan
Sami Ullah
B. Khan
Sep 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 11872 - 11890 · 0 citations
· 42 references
Medicine
Abstract
Dual glucagon‐like peptide‐1/glucagon receptor (GLP‐1/GCGR) agonists represent a novel obesity treatment class, but existing meta‐analyses often conflate them with GIP‐containing agents (tirzepatide, retatrutide) or restrict analysis to one or two drugs, leaving class‐specific efficacy and safety incompletely characterized.